People | July 16, 2022
Enveda appoints Vanitha Sekar as Chief Business Officer
She joins Enveda from Gilead Sciences
She joins Enveda from Gilead Sciences
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Dr. Rizo brings extensive industry leadership experience to Vividion, having held multiple senior executive roles during her career at both biotechnology and large pharmaceutical companies.
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
Subscribe To Our Newsletter & Stay Updated
